Novo Nordisk Pharmaceutical Industries, Lp drugs

3 results
  • ozempic - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Ozempic is used alongside diet and exercise to improve blood sugar in adults with type 2 diabetes. It also reduces the risk of serious cardiovascular events in those with established heart disease, and lowers the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
  • rybelsus - oral semaglutide tablet

    (Oral Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Ozempic is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It also reduces the risk of serious cardiovascular events—including CV death, heart attack, and stroke—in adults with type 2 diabetes at high cardiovascular risk.
  • wegovy - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk Pharmaceutical Industries, Lp
    Wegovy (semaglutide) is used with diet and exercise to reduce cardiovascular event risk in adults with obesity or overweight and established CV disease, for long-term weight reduction in adults and patients 12+ with obesity or overweight, and to treat noncirrhotic MASH with moderate-to-advanced liver fibrosis in adults.